v3.26.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,247,269 $ 4,622,331
Short-term investment securities 1,361,043 2,698,661
Restricted cash 908,459 1,231,168
Interest receivable 12,423 35,129
Accounts receivable 996,464 1,090,297
Prepaid expenses and other current assets 174,238 219,067
Total current assets 7,699,896 9,896,653
Non-current assets:    
Long-term investment securities 74,812
Operating lease right-of-use asset, net 24,354 38,535
Other assets 10,511 10,537
Total assets 7,809,573 9,945,725
Current liabilities:    
Accounts payable 1,060,092 852,024
Accrued expenses 891,420 967,974
Deferred research and development obligations 1,110,570 1,730,852
Operating lease liability 19,998 34,621
Total current liabilities 3,183,880 3,687,271
Non-current liabilities:    
Total liabilities 8,217,305 8,713,315
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock, $.0001 par value: Authorized shares - 5,000,000; none issued and outstanding
Common stock, $.001 par value: Authorized shares - 100,000,000; issued shares - 48,692,205 and 48,441,300, outstanding shares - 36,438,703 and 36,187,798 as of March 31, 2026, and December 31, 2025, respectively 48,693 48,442
Additional paid-in capital 113,879,281 113,564,991
Treasury stock, shares held at cost - 12,253,502 (18,929,915) (18,929,915)
Accumulated deficit (95,405,791) (93,451,108)
Total stockholders’ equity (407,732) 1,232,410
Total liabilities and stockholders’ equity 7,809,573 9,945,725
Nonrelated Party [Member]    
Current liabilities:    
Accrued interest 60,000 60,000
Non-current liabilities:    
Convertible notes, net of issuance costs 2,966,646 2,962,304
Related Party [Member]    
Current liabilities:    
Accrued interest 41,800 41,800
Non-current liabilities:    
Convertible notes, net of issuance costs $ 2,066,779 $ 2,063,740